White blood cell (WBC) >= /uL
White blood cell (WBC) >= ,/ul
White blood cell (WBC) >= ,/uL
White blood cell (WBC) greater than or equal to ,/ul
White blood cell (WBC) ? . K/uL
White blood cell count (WBC) > /uL
White blood cell (WBC) >= /uL
White blood cell (WBC) > /ul within four weeks of enrollment
White blood cell (WBC) count >= ,/uL
White blood cell (WBC) counts > /uL.
White blood cell count (WBC) >= /uL.
Obtained within  days prior to randomization/registration: white blood cell (WBC ) >= /uL
White blood cell (WBC) count of > /ul
White blood cell (WBC) counts > /uL.
White blood cell (WBC) count < ,/uL before administration of pevonedistat on cycle  day ; Note: hydroxyurea may be used to control the level of circulating leukemic blast cell counts to not lower than ,/uL during the study
Obtained within  days of the first study treatment: White blood cell (WBC) count > /uL
White blood cell (WBC) >= /uL within  days of registration
Obtained within  days prior to randomization/registration: White blood cell (WBC) >= /uL.
Obtained within  days of the first study treatment: White blood cell (WBC) count > /uL
White blood cell (WBC) counts > /uL
Obtained within  days prior to the first study treatment (cycle , day ): white blood cell (WBC) counts > /uL
White blood cell (WBC) count of >= /ul
Leukocytes (white blood cell [WBC]) >= ,/uL
White blood cell count (WBC) >= /uL
White blood cell (WBC) >= /uL
White blood cell (WBC) >= /uL, within  days before study registration
Within  days prior to the first study treatment (cycle , day ): White blood cell (WBC) counts > /uL
White blood cell (WBC) counts > /uL
Performed within  days (+  working days) prior to registration: White blood cell (WBC) > ,/ul.
White blood cell count (WBC) >= ,/uL
Total white blood cell (WBC) count >= /uL, within  days of study registration (within  days for pulmonary and cardiac assessments)
White blood cell (WBC) counts > /uL within  days prior to the first study treatment (cycle , day )
White blood cell count (WBC) >= /uL should be obtained within  days prior to enrollment
White blood cell (WBC) >= /uL
White blood count (WBC) >= /uL obtained within  days prior to randomization/registration
White blood cell counts (WBC) > /uL
Within  days prior to study entry: White blood cell (WBC) >= /uL
White blood cell count (WBC) >= /uL
White blood cell (WBC) count > /uL
Must be met within  days of course  day  (CD): White blood cell (WBC) >= ,/ul
White blood cell (WBC) >= ,/uL
White blood cell (WBC) >= ,/uL obtained no more than  days prior to the start of neoadjuvant endocrine therapy
White blood cell (WBC) >= /uL
White blood count (WBC) > ,/uL
White blood cell (WBC) >= /uL
White blood cell (WBC) >= ,/ul
Within  days prior to the first study treatment (cycle , day ): White blood cell (WBC) counts >= /uL.
WBC (white blood cell count) is /ul
White blood cell (WBC) >= . x ^/ul
White blood cell (WBC) less than or equal to /uL
White blood cell (WBC) counts > /uL, obtained within  days prior to the first study treatment (cycle , day )
Performed within  days prior to study: White blood count (WBC) > ,/ul
White blood cell (WBC) >= . x ^/ul
White blood cell (WBC) >= ,/uL
White blood cell (WBC) counts > /uL
White blood cell (WBC) > /ul
No exclusion for blood counts; however, at the time of treatment initiation, white blood cell (WBC) should be < ,/uL (can be controlled with hydroxyurea)
White blood cell count (WBC) >= /ul
White blood cell (WBC) > ,/ul
White blood cell (WBC) greater than or equal to ,/ul
White blood cell (WBC) >= /UL
White blood cell (WBC) >= /uL
White blood cell (WBC) count >= /ul, obtained within  days prior to initiation of study treatment
White blood cell (WBC) >= /uL
White blood cell (WBC) count >= /uL
White blood cell (WBC) >= /ul
White blood cell (WBC) count of >= /ul
White blood cell (WBC) > ,/ul
White blood cell (WBC) >= ,/ul
Obtained within  days prior to the first study treatment (cycle , day ); white blood cell (WBC) counts > /uL
White blood cell (WBC) count of >= /ul
White blood cell (WBC) >= ,/ul
Whole blood cell (WBC) >= ,/ul
White blood cell (WBC) >= /uL
White blood cell (WBC) >= /uL
White blood cell (WBC) counts > /uL (obtained within  days prior to the first study treatment [course , day ])
White blood cell (WBC) > /ul
White blood cell (WBC) > /uL
White blood cell (WBC): >= /uL (~ x ^/L)
White blood count (WBC) of >  ul 
White blood cell (WBC) >= /uL
White blood cell (WBC) >= , /uL
White blood cell (WBC) >= . K/uL
White blood cell (WBC) > . K/uL
White blood cell count (WBC) >= ,/uL
Total absolute phagocyte count (APC = %neutrophils + %monocytes) X white blood cell (WBC) is at least /uL
White blood cell (WBC) >= /uL
White blood cell (WBC) >= ,/uL
White blood cell (WBC) > . k/uL
White blood cell (WBC) >= ,/uL
Leukocytes >= ,/uL; Note: if leukopenia is idiopathic and no other significant co-morbidities exist patients will not be excluded on the basis of their white blood cell (WBC)
White blood cell count (WBC) >= ,/ul
White blood cell (WBC) < /uL
White blood cell (WBC) >= ,/uL, performed within  days prior to registration